🔎 Trials Near Me

Pradžia › Širdies priepuolis › Tennessee

Širdies priepuolis klinikiniai tyrimai Tennessee

5 tyrimai dėl Širdies priepuolis ieško dalyvių vietose Tennessee.

Miestai Tennessee

Oficialus tyrimo tekstas (anglų kalba)

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • Southeast Renal Research Institute, Chattanooga
  • Dialysis Clinic Inc - University Nephology, Knoxville
  • Knoxville Kidney Center PLLC, Knoxville
  • ir dar 2
Renkami dalyviai2/3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-21 · NCT05485961

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

  • The Stern Cardiovascular Foundation, Germantown
  • Apex Cardiology Research Associates of Jackson, Jackson
  • Vanderbilt Univ Medi Cen, Nashville
  • ir dar 1
Renkami dalyviai3 fazė
Amžius nuo 18 iki 100 · Visoms lytims · Atnaujinta 2026-09-04 · NCT07517263

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

  • Erlanger Health, Inc., Chattanooga
  • Ascension Saint Thomas, Nashville
  • Parkway Cardiology Associates, Oak Ridge
  • ir dar 1
Renkami dalyviai3 fazė
Amžius nuo 50 iki 105 · Visoms lytims · Atnaujinta 2026-08-21 · NCT07136012

Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

  • Vanderbilt University Medical Center, Nashville
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-03-24 · NCT04774159

Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence

  • University of Tennessee Medical Center, Knoxville
  • University of Tennessee Health Science Center/Regional One Health, Memphis
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-01-29 · NCT06374277

Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.